1. Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome
   Tanja Zeller et al, 2018, Biomolecules CrossRef
2. Rationale and design of the open-label, prospective, randomized study of the efficacy of intravenous versus oral iron deficiency therapy in improving left ventricular systolic function in patients with myocardial infarction (OPERA-MI)
   D R Khastieva et al, 2022, Russian Journal of Cardiology CrossRef
3. Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease—First Report on the Prospective Relevance of Intrinsic Iron Release
   Julia Ruhe et al, 2018, Biomolecules CrossRef
4. Identification of three mechanistic pathways for iron-deficient heart failure
   Milton Packer et al, 2024, European Heart Journal CrossRef
5. Iron deficiency in patients with coronary artery disease
   D. R. Khastieva et al, 2022, Russian Journal of Cardiology CrossRef
6. Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives
   Francesco Corradi et al, 2023, Cardiovascular Research CrossRef
7. Aerobic exercise-induced HIF-1α upregulation in heart failure: exploring potential impacts on MCT1 and MPC1 regulation
   Longfei Xu et al, 2024, Molecular Medicine CrossRef
8. The influence of iron availability on the structural changes of skeletal muscle cells and cardiac muscle cells
   Kamil A. Kobak, 2021, Postępy Polskiej Medycyny i Farmacji CrossRef
9. Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression
   Kamil A. Kobak et al, 2021, Cells CrossRef
10. Iron Deficiency and Deranged Myocardial Energetics in Heart Failure
    Michał Tkaczyszyn et al, 2022, International Journal of Environmental Research and Public Health CrossRef
11. Iron Status and Short-Term Recovery after Non-Severe Acute Myocarditis: A Prospective Observational Study
    Paweł Franczuk et al, 2023, Biomedicines CrossRef
12. Structural and functional abnormalities in iron-depleted heart
    Kamil A Kobak et al, 2019, Heart Failure Reviews CrossRef
13. Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions
    Kamil Kobak et al, 2018, International Journal of Molecular Medicine CrossRef
14. Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
    Ridha Alnuwaysir et al, 2021, Journal of Clinical Medicine CrossRef
15. Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study
    Henri Weidmann et al, 2020, Journal of the American Heart Association CrossRef
16. Impact of different methods of induction of cellular hypoxia: focus on protein homeostasis signaling pathways and morphology of C2C12 skeletal muscle cells differentiated into myotubes
    Samir Bensaid et al, 2019, Journal of Physiology and Biochemistry CrossRef
17. In-depth review: is hepcidin a marker for the heart and the kidney?
    Rengin Elsurer Afsar et al, 2021, Molecular and Cellular Biochemistry CrossRef
18. Potential role for pyruvate kinase M2 in the regulation of murine cardiac glycolytic flux during in vivo chronic hypoxia
    Michal K. Handzlik et al, 2021, Bioscience Reports CrossRef